Gaps in access to essential medicines and health products for noncommunicable diseases and mental health conditions

Affiliations

¹ Division of Universal Health Coverage, Communicable and Noncommunicable Diseases, World Health Organization, avenue Appia 20, 1211 Geneva 27, Switzerland.
² Division of Access to Medicines and Health Products, World Health Organization, Geneva, Switzerland.

Editorial

Ren Minghui et al. Bull World Health Organ. 2020.

. 2020 Sep 1;98(9):582-582A.

doi: 10.2471/BLT.20.272658.

¹ Division of Universal Health Coverage, Communicable and Noncommunicable Diseases, World Health Organization, avenue Appia 20, 1211 Geneva 27, Switzerland.
² Division of Access to Medicines and Health Products, World Health Organization, Geneva, Switzerland.

No abstract available

References

1. A/RES/74/2. Political Declaration for the UN High-Level Meeting on Universal Health Coverage. In: Seventy-fourth session United Nations General Assembly, 23 September 2019. New York: United Nations; 2019. Available from: https://undocs.org/en/A/RES/74/2 [cited 2020 Jul 31].
1. COVID-19 significantly impacts health services for noncommunicable diseases. Geneva: World Health Organization; 2020. Available from : https://www.who.int/news-room/detail/01-06-2020-covid-19-significantly-i... [cited 2020 Jul 31].
1. Tackling NCDs: 'best buys' and other recommended interventions for the prevention and control of noncommunicable diseases. Geneva: World Health Organization; 2017. Available from: https://apps.who.int/iris/handle/10665/259232 [cited 2020 Jul 31].
1. Roadmap for access to medicines, vaccines and health products. 2019-2023: comprehensive support for access to medicines, vaccines and other health products. Geneva: World Health Organization; 2019. Available from: https://apps.who.int/iris/handle/10665/330145 [cited 2020 Jul 31].
1. WHO Model list of essential medicines. Geneva: World Health Organization; 2017. Available from: https://www.who.int/selection_medicines/list/en/ [cited 2020 Jul 31]